All News

AAC Accela Form - Proven Reliability in Temperature Controlled Shipping - PE Whitepaper

Pfizer's strategy to use Wyeth's drug pipeline to increase its sales has paid off as the drug giant announced that its fourth quarter earnings nearly doubled year-to-year. Too bad investors are running in fear of an ugly 2010 forecast.

California's biotech industry takes its own pulse in a new survey that tracks how the state is doing in serving as the nation's medicine cabinet and avatar of drug innovation.

Shire’s Second Act

Innovation won't happen until the industry is ready to sit down and make a big change.

Data Governance: Business Data You Can Believe In - Kalido Whitepaper

All eyes are on PatientsLikeMe's new epilepsy site. The social network is backed by UCB, but the pharma firm is taking a hands-off approach. Is this the future of pharma social media?

Business Intelligence Case study: Abbott Laboratories - Kalido Whitepaper

Kalido KONA Information Appliance for Pharmaceutical Sales & Marketing Analytics - Kalido whitepaper

AIDS treatment provider says the high price of Merck's Isentress is limiting patient access. Merck says banning its reps is what limits access. While Mom and Dad are fighting, does the patient lose out?

GlaxoSmithKline announced that it would open up its library of prospective molecules and investigational vaccines. This move gives researchers free access to study experimental treatments for illnesses that plague the world's poorest countries.

Pharma Complaint Management : Emerging Challenges and Solutions - Infosys Tech

At time when people can't even get a 3 percent cost-of-living increase, how can pharma justify price hikes pushing 500 percent (in some categories). A new study by the government's General Accountability Office examines why drug products took a massive price leap in recent years.

The push for government transparency continues with Phase I of FDA's plan to expose the inner workings of that secretive cabal known as the Food and Drug Association. First up, fancy new FAQs.

A new JAMA study reveals that antidepressants might not have as strong an effect on people with less severe cases of depression. How this will affect the pharma industry, which once made heaps of cash with drugs like Prozac, remains to be seen.

January 04. 2010.

The Big Reset

Thank you

Pharma must get its definitions right to be successful in the new decade.

December 23, 2009.

Waters Video Showcase is accessible at waters.com/customers and is the largest such assemblage of expert testimonials in the industry.

December 18, 2009.

December 17, 2009.

Sanofi-Aventis is recalling hundreds of thousands of doses of the childrens' version of its H1N1 vaccine. Conspiracy theorists are going to have a field day.

Transparency can be a double-edged sword - especially if you are a doctor receiving money to speak on behalf of a drug company. Sure the pay day is nice, but does the public outing open you up to scrutiny?

It's been a tough week for clinical trials: One drug got canned and another was re-tuned in the wake of failed end points and patient deaths.

December 15, 2009.

PharmRep Editorial Calendar

11 December.